BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6482321)

  • 41. Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.
    Núñez M; Martín G; Cocca C; Mohamad N; Gutiérrez A; Cricco G; Medina V; Rivera E; Croci M; Crescenti E; Bergoc R
    Anticancer Res; 2006; 26(3A):2113-22. PubMed ID: 16827153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats.
    Shimano N; Uehara N; Kiyozuka Y; Shikata N; Tsubura A
    In Vivo; 2007; 21(6):983-8. PubMed ID: 18210745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia.
    Stoica G; Koestner A; Capen CC
    Anticancer Res; 1984; 4(1-2):5-12. PubMed ID: 6712176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inhibition of mammary gland carcinogenesis using a tincture from biomass of ginseng tissue culture].
    Bespalov VG; Aleksandrov VA; Davydov VV; Limarenko AIu; Molokovskiĭ DS; Petrov AS; Slepian LI; Trilis IaG
    Biull Eksp Biol Med; 1993 Jan; 115(1):59-61. PubMed ID: 8054582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth enhancement of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar by estrogen or prolactin.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5605-8. PubMed ID: 6498820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nimesulide and melatonin in mammary carcinogenesis prevention in female Sprague-Dawley rats.
    Kubatka P; Kalická K; Chamilová M; Ahlersová E; Ahlers I; Bojková B; Adámeková E
    Neoplasma; 2002; 49(4):255-9. PubMed ID: 12382025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 489():1-148. PubMed ID: 12563342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensitivity of N-nitrosomethylurea-induced rat mammary tumors to cis-hydroxyproline, an inhibitor of collagen production.
    Lewko WM; Liotta LA; Wicha MS; Vonderhaar BK; Kidwell WR
    Cancer Res; 1981 Jul; 41(7):2855-62. PubMed ID: 7018671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy.
    Jin Z; Houle B; Mikheev AM; Cha RS; Zarbl H
    Cancer Res; 1996 Nov; 56(21):4927-35. PubMed ID: 8895746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronotherapy of breast cancer induced by N-nitrosomethylurea in the rat. I. Effect of a high dose of cyclophosphamide administered at 8:00 and 14:00 hours].
    Pérez-López FR; Urcia M; Torralba R; Lafarga L; Leal MC; Guillén V; Hergueta J
    Rev Esp Oncol; 1984; 31(3):401-7. PubMed ID: 6546168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of perinatal nicotine administration on transplacental carcinogenesis in Sprague Dawley rats by N-methylnitrosourea.
    Berger MR; Petru E; Habs M; Schmähl D
    Br J Cancer; 1987 Jan; 55(1):37-40. PubMed ID: 3814474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha 2 interferon in the prevention of N-nitroso-methyl urea induced breast cancer in rats.
    Hershman MJ; Habib NA; Apostolov K; Barker W; Wood CB
    Eur J Surg Oncol; 1988 Jun; 14(3):249-51. PubMed ID: 3371477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrous cycle dependence of nitrosomethylurea (NMU)-induced preneoplastic lesions in rat mammary gland.
    Anderson CH; Hussain RA; Han MC; Beattie CW
    Cancer Lett; 1991 Jan; 56(1):77-84. PubMed ID: 2004357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dependence of the carcinogenic effect of N-nitrosomethylurea on its dosage and the age of female rats].
    Anisimov VN
    Vopr Onkol; 1987; 33(1):65-72. PubMed ID: 3811313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppressive effects of capsaicin against N-nitrosomethylurea-induced mammary tumorigenesis in rats.
    El-Kott AF; Bin-Meferij MM
    Biomed Pharmacother; 2018 Feb; 98():673-679. PubMed ID: 29294454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of age on dose-response relationship in carcinogenesis induced by single administration of N-nitrosomethylurea in female rats.
    Anisimov VN
    J Cancer Res Clin Oncol; 1988; 114(6):628-35. PubMed ID: 3204110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Modifying effect of thyroid gland functional disorders on realization of transplacental carcinogenesis induced by N-nitrosomethylurea in rats].
    Popovich IG; Aleksandrov VA; Blinova GA; Napalkov NP
    Vopr Onkol; 1985; 31(8):79-85. PubMed ID: 4036068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The development of mammary gland tumors induced in rats by aromatic hydrocarbons].
    Beskrovnyĭ AM; Breslavskiĭ AS; Sukacheva OA
    Vopr Onkol; 1970; 16(2):59-63. PubMed ID: 5462184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.